Teladoc (TDOC) Stock Forecast & Price Target

Teladoc Health is positioned for a constructive outlook because its Integrated Care segment has continued to deliver consistent, steady growth while BetterHelp’s insurance business is scaling faster than expected and offsetting the decline in cash-pay demand. Management’s improved visibility into this transition led to tighter FY26 revenue guidance of $2,395mm-$2,441mm and a higher adjusted EBITDA floor of $277mm-$303mm, reinforcing confidence in earnings durability. With BetterHelp projected to keep growing sequentially and reach a revenue run-rate of more than $200M exiting 2027 versus about $140M currently, the company appears well placed to benefit from favorable telehealth adoption and market-share gains.

Teladoc Health is facing a weakening growth profile because management expects 2027 advertising spending to fall in the mid-to-high-20% range, which will likely further pressure cash-pay revenue in BetterHelp. Although BetterHelp insurance revenue improved to a $140 million annual run rate in 3Q from $110 million in 2Q, the company’s shift away from cash-pay and toward insurance is accelerating declines, while integrated care bookings were only “generally inline,” limiting confidence in a return to topline growth in FY27. On top of that, urgent care telehealth is becoming commoditized and the company must prove specialty care can deliver differentiated health outcomes or savings, or else it risks losing share in a highly competitive market.